Quantitative proteomics suggests decrease in the secretogranin-1 cerebrospinal fluid levels during the disease course of multiple sclerosis

A.C. Kroksveen, J.D. Jaffe, E. Aasebo, H. Barsnes, Y. Bjorlykke, D. Franciotta, H. Keshishian, K.M. Myhr, J.A. Opsahl, V. van Pesch, C.E. Teunissen, O. Torkildsen, R.J. Ulvik, H. Vethe, S.A. Carr, F.S. Berven

Research output: Contribution to journal › Article › Academic › peer-review

Original languageUndefined/Unknown
Pages (from-to)3361-3369
JournalProteomics
Volume15
Issue number19
DOIs
Publication statusPublished - 2015

Cite this

Kroksveen, A. C., Jaffe, J. D., Aasebo, E., Barsnes, H., Bjorlykke, Y., Franciotta, D., ... Berven, F. S. (2015). Quantitative proteomics suggests decrease in the secretogranin-1 cerebrospinal fluid levels during the disease course of multiple sclerosis. Proteomics, 15(19), 3361-3369. https://doi.org/10.1002/pmic.201400142
Kroksveen, A.C. ; Jaffe, J.D. ; Aasebo, E. ; Barsnes, H. ; Bjorlykke, Y. ; Franciotta, D. ; Keshishian, H. ; Myhr, K.M. ; Opsahl, J.A. ; van Pesch, V. ; Teunissen, C.E. ; Torkildsen, O. ; Ulvik, R.J. ; Vethe, H. ; Carr, S.A. ; Berven, F.S. / Quantitative proteomics suggests decrease in the secretogranin-1 cerebrospinal fluid levels during the disease course of multiple sclerosis. In: Proteomics. 2015 ; Vol. 15, No. 19. pp. 3361-3369.
@article{4c5cd84b5e4841b2ae0c06101c864d19,
title = "Quantitative proteomics suggests decrease in the secretogranin-1 cerebrospinal fluid levels during the disease course of multiple sclerosis",
author = "A.C. Kroksveen and J.D. Jaffe and E. Aasebo and H. Barsnes and Y. Bjorlykke and D. Franciotta and H. Keshishian and K.M. Myhr and J.A. Opsahl and {van Pesch}, V. and C.E. Teunissen and O. Torkildsen and R.J. Ulvik and H. Vethe and S.A. Carr and F.S. Berven",
year = "2015",
doi = "10.1002/pmic.201400142",
language = "Undefined/Unknown",
volume = "15",
pages = "3361--3369",
journal = "Proteomics",
issn = "1615-9853",
publisher = "Wiley-VCH Verlag",
number = "19",

}

Kroksveen, AC, Jaffe, JD, Aasebo, E, Barsnes, H, Bjorlykke, Y, Franciotta, D, Keshishian, H, Myhr, KM, Opsahl, JA, van Pesch, V, Teunissen, CE, Torkildsen, O, Ulvik, RJ, Vethe, H, Carr, SA & Berven, FS 2015, 'Quantitative proteomics suggests decrease in the secretogranin-1 cerebrospinal fluid levels during the disease course of multiple sclerosis' Proteomics, vol. 15, no. 19, pp. 3361-3369. https://doi.org/10.1002/pmic.201400142

Quantitative proteomics suggests decrease in the secretogranin-1 cerebrospinal fluid levels during the disease course of multiple sclerosis. / Kroksveen, A.C.; Jaffe, J.D.; Aasebo, E.; Barsnes, H.; Bjorlykke, Y.; Franciotta, D.; Keshishian, H.; Myhr, K.M.; Opsahl, J.A.; van Pesch, V.; Teunissen, C.E.; Torkildsen, O.; Ulvik, R.J.; Vethe, H.; Carr, S.A.; Berven, F.S.

In: Proteomics, Vol. 15, No. 19, 2015, p. 3361-3369.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Quantitative proteomics suggests decrease in the secretogranin-1 cerebrospinal fluid levels during the disease course of multiple sclerosis

AU - Kroksveen, A.C.

AU - Jaffe, J.D.

AU - Aasebo, E.

AU - Barsnes, H.

AU - Bjorlykke, Y.

AU - Franciotta, D.

AU - Keshishian, H.

AU - Myhr, K.M.

AU - Opsahl, J.A.

AU - van Pesch, V.

AU - Teunissen, C.E.

AU - Torkildsen, O.

AU - Ulvik, R.J.

AU - Vethe, H.

AU - Carr, S.A.

AU - Berven, F.S.

PY - 2015

Y1 - 2015

U2 - 10.1002/pmic.201400142

DO - 10.1002/pmic.201400142

M3 - Article

VL - 15

SP - 3361

EP - 3369

JO - Proteomics

JF - Proteomics

SN - 1615-9853

IS - 19

ER -

Kroksveen AC, Jaffe JD, Aasebo E, Barsnes H, Bjorlykke Y, Franciotta D et al. Quantitative proteomics suggests decrease in the secretogranin-1 cerebrospinal fluid levels during the disease course of multiple sclerosis. Proteomics. 2015;15(19):3361-3369. https://doi.org/10.1002/pmic.201400142

Access to Document